Estimated annual conversion risk during follow-up among participants without detectable <i>Mtb</i> antigen immune responses at enrolment by <i>Mtb</i> infection status for 60 participants assessed more than once. Sascha Wilk Michelsen Bolette Soborg Lars Jorge Diaz Soren Tetens Hoff Else Marie Agger Anders Koch Ida Rosenkrands Jan Wohlfahrt Mads Melbye 10.1371/journal.pone.0177906.t003 https://plos.figshare.com/articles/dataset/Estimated_annual_conversion_risk_during_follow-up_among_participants_without_detectable_i_Mtb_i_antigen_immune_responses_at_enrolment_by_i_Mtb_i_infection_status_for_60_participants_assessed_more_than_once_/5059390 <p>Estimated annual conversion risk during follow-up among participants without detectable <i>Mtb</i> antigen immune responses at enrolment by <i>Mtb</i> infection status for 60 participants assessed more than once.</p> 2017-06-01 17:35:26 whole-blood antigen stimulation TB vaccine candidate antigens source population 65 participants East Greenlanders Mtb infection Mtb infection status characterise Mtb infection stage Mtb infection stage Mycobacterium tuberculosis 15 antigens TB notification system PPD Civil Registration System immunity Quantiferon-TB Gold testing 12 non-QFT antigens interferon gamma measurement